Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease

Ismail Elkhattib1, Kareem Wael Raafat2, Basant Elsayed3

  • 1Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68105, United States. ismailkhattib89@gmail.com.

World Journal of Hepatology
|September 3, 2025
PubMed

Insights

Hepatitis C virus (HCV) infection is linked to cardiovascular issues like atherosclerosis and cardiomyopathy. Viral load and steatosis are key risk factors, highlighting the need for further research into HCV and heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is primarily known for liver disease but is increasingly linked to cardiovascular complications.
  • Carotid atherosclerosis and cardiomyopathy are significant cardiovascular issues associated with chronic HCV infection.

Purpose of the Study:

  • To explore the association between Hepatitis C virus infection and cardiovascular complications.
  • To investigate the mechanisms underlying HCV-related atherosclerosis and cardiomyopathy.
  • To identify risk factors and understand the pathogenesis of cardiovascular disease in HCV patients.

Main Methods:

  • Review of studies investigating cardiovascular outcomes in patients with chronic Hepatitis C virus infection.
  • Analysis of risk factors such as viral load and steatosis.
  • Examination of molecular and cellular mechanisms including inflammation, oxidative stress, and immune responses.

Main Results:

  • Chronic HCV infection is associated with a higher prevalence of carotid atherosclerosis, with viral load and steatosis as independent risk factors.
  • HCV-related atherosclerosis involves endothelial dysfunction, inflammation (TNF-α, IL-6), oxidative stress (malondialdehyde), and immune dysregulation.
  • HCV infection contributes to cardiomyopathy through direct viral effects on cardiomyocytes and indirect immune-mediated damage, alongside a procoagulant imbalance (elevated Factor VIII).

Conclusions:

  • Substantial evidence links Hepatitis C virus infection to cardiovascular disease, including atherosclerosis and cardiomyopathy.
  • Mechanisms involve direct viral impact, inflammation, oxidative stress, immune responses, and altered coagulation.
  • Further research is required to confirm causality and inform therapeutic strategies for cardiovascular risk in HCV patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
77
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50